𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Activity and Safety of Oxaliplatin with Weekly 5-Fluorouracil Bolus and Low-Dose Leucovorin as First-Line Treatment for Advanced Colorectal Cancer

✍ Scribed by Javier Cassinello; Pilar Escudero; Antonieta Salud; Fernando Marcos; Eduardo Pujol; Ramón Pérez-Carrión; Antonio Colmenarejo; Ricardo González del Val; José Valero; Mauro J. Oruezábal; Vicente Guillem; Inés García; Alberto Arcediano; Xavier Marfà


Book ID
119934918
Publisher
CIG Media Group, LP.
Year
2003
Tongue
English
Weight
103 KB
Volume
3
Category
Article
ISSN
1533-0028

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Capecitabine plus oxaliplatin (XELOX) ve
✍ Michel Ducreux; Jaafar Bennouna; Mohamed Hebbar; Marc Ychou; Gérard Lledo; Thier 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 440 KB

## Abstract A regimen consisting of 5‐fluorouracil/leucovorin plus oxaliplatin (FOLFOX‐6) is widely used in France in the first‐line treatment of metastatic colorectal cancer (MCRC). The aim of our study was to demonstrate the non‐inferiority of capecitabine plus oxaliplatin (XELOX) __versus__ FOLF